Interpace Biosciences Inc
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $12.6M | $-22.0M | $-13.6M | $-16.8M | $-4.6M | $-25.5M | $-11.9M | $-6.8M |
| Depreciation & Amortization | $3.7M | $4.5M | $5.0M | $2.4M | $1.4M | $2.0M | $3.0M | $1.8M |
| Depreciation | $400.0K | $500.0K | $600.0K | $500.0K | $1.4M | $1.1M | $1.8M | — |
| Amortization | $3.3M | $3.8M | $3.8M | $773.0K | $0 | $900.0K | $900.0K | — |
| Stock-Based Compensation | $1.1M | $131.0K | $4.0M | $2.1M | $1.7M | $1.8M | $1.9M | $1.5M |
| Net Cash from Operating Activities | $-15.3M | $-7.6M | $-19.8M | $-16.4M | $-3.5M | $-10.3M | $2.0M | $16.4M |
| Investing Activities | ||||||||
| Capital Expenditures | $29.0K | — | $353.0K | $2.9M | $1.8M | $1.1M | $343.0K | $2.1M |
| Business Acquisitions | — | — | $0 | $13.4M | — | — | $0 | $23.9M |
| Net Cash from Investing Activities | $-29.0K | — | $26.4M | $-25.4M | $-3.3M | $-1.1M | $-343.0K | $-26.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | $208.0K | $228.0K | $314.0K | $156.0K | $16.0K | $62.0K |
| Net Cash from Financing Activities | $29.9M | $-101.0K | $-21.4M | $19.2M | $-314.0K | $-156.0K | $-16.0K | $-62.0K |
| Net Change in Cash | $14.6M | $-7.7M | $-14.8M | $-22.5M | $-7.1M | $-11.6M | $1.6M | $-9.8M |
| Free Cash Flow | $-15.3M | — | $-20.2M | $-19.2M | $-5.3M | $-11.4M | $1.6M | $14.2M |